Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Comput Struct Biotechnol J ; 20: 2247-2258, 2022.
Article in English | MEDLINE | ID: mdl-35615024

ABSTRACT

The burgeoning menace of antimicrobial resistance across the globe has necessitated investigations into other chemotherapeutic strategies to combat infections. Antimicrobial peptides, or host defense peptides, are a set of promising therapeutic candidates in this regard. Most of them cause membrane permeabilization and are a key component of the innate immune response to pathogenic invasion. It has also been reported that peptide self-assembly is a driving factor governing the microbicidal activity of these peptide candidates. While efforts have been made to develop novel synthetic peptides against various microbes, many clinical trials of such peptides have failed due to toxicity and hemolytic activity to the host. A function-guided rational peptide engineering, based on evolutionary principles, physicochemical properties and activity determinants of AMP activity, is expected to help in targeting specific microbes. Furthermore, it is important to develop a unified understanding of the evolution of AMPs in order to fully appreciate their importance in host defense. This review seeks to explore the evolution of AMPs and the physicochemical determinants of AMP activity. The specific interactions driving AMP self-assembly have also been reviewed, emphasizing implications of this self-assembly on microbicidal and immunomodulatory activity.

2.
Front Immunol ; 12: 582946, 2021.
Article in English | MEDLINE | ID: mdl-33815357

ABSTRACT

The causative agent of mumps is a single-stranded, non-segmented, negative sense RNA virus belonging to the Paramyxoviridae family. Besides the classic symptom of painfully swollen parotid salivary glands (parotitis) in mumps virus (MuV)-infected men, orchitis is the most common form of extra-salivary gland inflammation. Mumps orchitis frequently occurs in young adult men, and leads to pain and swelling of the testis. The administration of MuV vaccines in children has been proven highly effective in reducing the incidence of mumps. However, a recent global outbreak of mumps and the high rate of orchitis have recently been considered as threats to male fertility. The pathogenesis of mumps orchitis remains largely unclear due to lack of systematic clinical data analysis and animal models studies. The alarming increase in the incidence of mumps orchitis and the high risk of the male fertility have thus become a major health concern. Recent studies have revealed the mechanisms by which MuV-host cells interact and MuV infection induces inflammatory responses in testicular cells. In this mini-review, we highlight advances in our knowledge of the clinical aspects and possible mechanisms of mumps orchitis.


Subject(s)
Infertility, Male/immunology , Mumps virus/immunology , Mumps/immunology , Orchitis/immunology , Host-Pathogen Interactions/immunology , Humans , Infertility, Male/complications , Infertility, Male/prevention & control , Male , Mumps/complications , Mumps/virology , Mumps Vaccine/administration & dosage , Mumps Vaccine/immunology , Mumps virus/physiology , Orchitis/complications , Orchitis/virology , Risk Factors , Vaccination/methods
3.
Hum Vaccin Immunother ; 17(9): 3153-3155, 2021 09 02.
Article in English | MEDLINE | ID: mdl-33877956

ABSTRACT

In Japan, monovalent vaccine against mumps virus (MuV) infection was shifted to a voluntary basis vaccination due to the incidences of aseptic meningitis in the past. According to an analysis of a total of 409 participants aged 18-20 years, overall vaccination coverage rate was 48%. The mean anti-MuV IgG antibody titer of participants with medical history and more than two times vaccination was significantly higher than that in those without a medical history and unvaccinated and single vaccination, respectively. Seropositivity against MuV infection was >50% regardless of the number of vaccinations. Although these results suggest that seropositivity may persist due to asymptomatic infection, it is necessary to implement either a high vaccine coverage or routine vaccination for prevention of periodic mumps epidemics.


Subject(s)
Mumps , Humans , Immunoglobulin G , Japan/epidemiology , Mumps/epidemiology , Mumps/prevention & control , Mumps Vaccine , Seroepidemiologic Studies , Vaccination , Vaccination Coverage , Young Adult
4.
Virol Sin ; 36(3): 521-536, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33284397

ABSTRACT

Although a live attenuated vaccine is available for controlling mumps virus (MuV), mumps still outbreaks frequently worldwide. The attenuated MuV vaccine strain S79 is widely used in mumps vaccination in China, but still with many shortcomings, among which the most prominent are the side effects and decreased immunity. Therefore, there is a need to further improve the safety and efficacy of the current MuV vaccine. In the present study, we further attenuated MuV S79 vaccine strain by inhibiting viral mRNA methyltransferase (MTase). We generated a panel of eight recombinant MuVs (rMuVs) carrying mutations in the MTase catalytic site or S-adenosylmethionine (SAM) binding site in the large (L) polymerase protein. These rMuVs are genetically stable and seven rMuVs are more attenuated in replication in cell culture and five rMuVs are more attenuated in replication in lungs of cotton rats compared with the parental vaccine strain S79. Importantly, cotton rats vaccinated with these seven rMuV mutants produced high levels of serum neutralizing antibodies and were completely protected against challenge with a wild-type MuV strain (genotype F). Therefore, our results demonstrate that alteration in the MTase catalytic site or SAM binding site in MuV L protein improves the safety or the immunogenicity of the MuV vaccine and thus mRNA cap MTase may be an effective target for the development of new vaccine candidates for MuV.


Subject(s)
Methyltransferases , Mumps Vaccine , China , Methyltransferases/genetics , Mumps virus/genetics , Mumps virus/immunology , RNA, Messenger/genetics
5.
Comput Biol Med ; 100: 253-258, 2018 09 01.
Article in English | MEDLINE | ID: mdl-28941550

ABSTRACT

We introduce a deep learning architecture for structure-based virtual screening that generates fixed-sized fingerprints of proteins and small molecules by applying learnable atom convolution and softmax operations to each molecule separately. These fingerprints are further non-linearly transformed, their inner product is calculated and used to predict the binding potential. Moreover, we show that widely used benchmark datasets may be insufficient for testing structure-based virtual screening methods that utilize machine learning. Therefore, we introduce a new benchmark dataset, which we constructed based on DUD-E, MUV and PDBBind databases.


Subject(s)
Databases, Protein , Deep Learning , Proteins/chemistry , Protein Conformation
6.
Hum Vaccin Immunother ; 11(7): 1865-71, 2015.
Article in English | MEDLINE | ID: mdl-26011746

ABSTRACT

The development and production of viral vaccines, in general, involve several steps that need the monitoring of viral load throughout the entire process. Applying a 2-step quantitative reverse transcription real time PCR assay (RT-qPCR), viral load can be measured and monitored in a few hours. In this context, the development, standardization and validation of a RT-qPCR test to quickly and efficiently quantify yellow fever virus (YFV) in all stages of vaccine production are extremely important. To serve this purpose we used a plasmid construction containing the NS5 region from 17DD YFV to generate the standard curve and to evaluate parameters such as linearity, precision and specificity against other flavivirus. Furthermore, we defined the limits of detection as 25 copies/reaction, and quantification as 100 copies/reaction for the test. To ensure the quality of the method, reference controls were established in order to avoid false negative results. The qRT-PCR technique based on the use of TaqMan probes herein standardized proved to be effective for determining yellow fever viral load both in vivo and in vitro, thus becoming a very important tool to assure the quality control for vaccine production and evaluation of viremia after vaccination or YF disease.


Subject(s)
Real-Time Polymerase Chain Reaction/standards , Yellow Fever Vaccine/genetics , Yellow Fever Vaccine/standards , Yellow Fever/immunology , Yellow Fever/prevention & control , Yellow fever virus/genetics , Animals , Antibody Specificity , Chlorocebus aethiops , Humans , Plasmids/genetics , Quality Control , RNA, Viral/immunology , RNA, Viral/isolation & purification , Reference Standards , Reproducibility of Results , Vero Cells , Viral Load , Viremia/virology , Yellow Fever/virology , Yellow Fever Vaccine/immunology , Yellow fever virus/immunology
7.
Virology ; 446(1-2): 162-72, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24074578

ABSTRACT

Nipah virus (NiV) is a recently emerged severe human pathogen that belongs to the Henipavirus genus within the Paramyxoviridae family. The NiV genome is encapsidated by the nucleoprotein (N) within a helical nucleocapsid that is the substrate used by the polymerase for transcription and replication. The polymerase is recruited onto the nucleocapsid via its cofactor, the phosphoprotein (P). The NiV P protein has a modular organization, with alternating disordered and ordered domains. Among these latter, is the P multimerization domain (PMD) that was predicted to adopt a coiled-coil conformation. Using both biochemical and biophysical approaches, we show that NiV PMD forms a highly stable and elongated coiled-coil trimer, a finding in striking contrast with respect to the PMDs of Paramyxoviridae members investigated so far that were all found to tetramerize. The present results therefore represent the first report of a paramyxoviral P protein forming trimers.


Subject(s)
Nipah Virus/chemistry , Nipah Virus/physiology , Phosphoproteins/chemistry , Phosphoproteins/metabolism , Protein Interaction Domains and Motifs , Protein Multimerization , Viral Proteins/chemistry , Viral Proteins/metabolism , Humans , Protein Conformation , Scattering, Small Angle , Ultracentrifugation
SELECTION OF CITATIONS
SEARCH DETAIL